Articles published by Newleos Therapeutics, Inc.

Newleos Therapeutics CEO David Donabedian Recognized by Goldman Sachs as One of the Most Exceptional Entrepreneurs at the 2025 Builders and Innovators Summit

October 15, 2025

From Newleos Therapeutics, Inc.

Via Business Wire

Tickers GS

Newleos Therapeutics Announces Clinical Progress Across Neuropsychiatric Pipeline

September 30, 2025

From Newleos Therapeutics, Inc.

Via Business Wire

Newleos Therapeutics Announces Poster Presentation to be Featured at the 2025 World Congress of Biological Psychiatry

September 09, 2025

From Newleos Therapeutics, Inc.

Via Business Wire

Newleos Therapeutics Appoints Stephen Brannan to Board of Directors and Announces NTX-1955 Clinical Progress in Generalized Anxiety Disorder

July 23, 2025

From Newleos Therapeutics, Inc.

Via Business Wire

Newleos Therapeutics Announces Clinical Advisory Board to Support Key Neuropsychiatry Programs

April 29, 2025

From Newleos Therapeutics, Inc.

Via Business Wire

Newleos Therapeutics Expands Leadership Team to Advance its Clinical-Stage Neuropsychiatric Programs and Drive Corporate Growth

April 08, 2025

From Newleos Therapeutics, Inc.

Via Business Wire

Newleos Therapeutics Debuts with $93.5 Million Oversubscribed Series A Financing to Transform the Treatment of Neuropsychiatric Disorders through the Advancement of Novel Medicines

February 13, 2025

From Newleos Therapeutics, Inc.

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.